SunTrust Starts Revance Therapeutic (RVNC) at Buy
Tweet
Share
E-mailGet Alerts RVNC Hot Sheet
Price: $3.65 --0%
Rating Summary:
4 Buy, 14 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 26
Rating Summary:
4 Buy, 14 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 26
Join SI Premium – FREE
SunTrust Robinson Humphrey initiated coverage on Revance Therapeutic (NASDAQ: RVNC) with a Buy rating and a price target of $46.00.
For an analyst ratings summary and ratings history on Revance Therapeutic click here. For more ratings news on Revance Therapeutic click here.
Shares of Revance Therapeutic closed at $17.10 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Needham Starts Faeth Therapeutics (FTH) at Buy
- BofA Securities Starts Mobility Global (MBGL) at Neutral
- Keefe, Bruyette & Woods Resumes Bank of Montreal (BMO:CN) (BMO) at Outperform
Create E-mail Alert Related Categories
New CoverageRelated Entities
SunTrust Robinson HumphreySign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
